Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low Dose Naltrexone for the Treatment of Juvenile Primary Fibromyalgia Syndrome

NCT00855972 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT00855972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00855972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low Dose Naltrexone for the Treatment of Juvenile Primary Fibromyalgia Syndrome
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Withdrawn
Start date
August 31, 2010
Completion date
December 31, 2011
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia